Metabolic profiling of serum using Ultra Performance Liquid Chromatography and the LTQ-Orbitrap mass spectrometry system. by Dunn, W, Broadhurst, D, Brown, M, Baker, P, Redman, C, Kenny, L, Kell, D

Detection and identification of novel metabolomic biomarkers in preeclampsia. by Kenny, L, Broadhurst, D, Brown, M, Dunn, W, Redman, C, Kell, D, Baker, P

Core Outcome Set for GROwth restriction: deVeloping Endpoints (COSGROVE) by Healy, P, Gordijn, S, Ganzevoort, W, Beune, I, Baschat, A, Khalil, A, Kenny, L, Bloomfield, F, Daly, M, Papageorghiou, AT, Devane, D

Diagnostic accuracy of placental growth factor in women with suspected preeclampsia: a prospective multicenter study. by Chappell, L, Duckworth, S, Seed, P, Griffin, M, Myers, J, Mackillop, L, Simpson, N, Waugh, J, Anumba, D, Kenny, L, Redman, C, Shennan, A

A Core Outcome Set for the prevention and treatment of fetal GROwth restriction: deVeloping Endpoints: The COSGROVE study by Healy, P, Gordijn, SJ, Ganzevoort, W, Beune, IM, Baschat, A, Khalil, A, Kenny, L, Bloomfield, FH, Daly, M, Kirkham, J, Devane, D, Papageorghiou, AT

Mortality in the UK STRIDER trial of sildenafil therapy for the treatment of severe early-onset fetal growth restriction by Sharp, A, Cornforth, C, Jackson, R, Harrold, J, Turner, MA, Kenny, L, Baker, PN, Johnstone, ED, Khalil, A, von Dadelszen, P, Papageorghiou, AT, Alfirevic, Z

Variation in outcome reporting in randomized controlled trials of interventions for prevention and treatment of fetal growth restriction by Townsend, R, Sileo, S, Stocker, L, Kumbay, H, Healy, P, Gordijn, S, Ganzevoort, W, Beune, I, Baschat, A, Kenny, L, Bloomfield, F, Daly, M, Devane, D, Papageorghiou, A, Khalil, A

STRIDER (Sildenafil TheRapy in dismal prognosis early onset fetal growth restriction): an international consortium of randomised placebo-controlled trials by Pels, A, Kenny, L, Alfirevic, Z, Baker, P, von Dadelszen, P, Gluud, C, Kariya, C, Mol, B, Papageorghiou, A, van Wassenaer-Leemhuis, A, Ganzevoort, W, Groom, K, International STRIDER Consortium

Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib by Coombes, RC, Howell, S, Lord, SR, Kenny, L, Mansi, J, Mitri, Z, Palmieri, C, Chap, LI, Richards, P, Gradishar, W, Sardesai, S, Melear, J, O’Shaughnessy, J, Ward, P, Chalasani, P, Arkenau, T, Baird, RD, Jeselsohn, R, Ali, S, Clack, G, Bahl, A, McIntosh, S, Krebs, MG

Maternal sildenafil for severe fetal growth restriction (STRIDER): a multicentre, randomised, placebo-controlled, double-blind trial by Sharp, A, Cornforth, C, Jackson, R, Harrold, J, Turner, M, Kenny, L, Baker, P, Johnstone, E, Khalil, A, von Dadelszen, P, Papageorghiou, A, Alfirevic, Z, Agarwal, U, Willis, E, Mammarella, S, Masson, G, Aquilina, J, Greco, E, Higgins, S, Vinayagam, D, Shaw, L, Stephens, L, Howe, D, Rand, A, Patni, S, Mousa, T, Rabab, A, Russell, H, Hannon, T, Fenn, A, Kilby, M, Selman, T, David, A, Spencer, R, Cohen, K, Breeze, A, McKelvey, A, Impey, L, Loannou, C, Stock, S, Poon, L, Pasupathy, D, Webster, L, Bugg, G